Advicenne: Advicenne Finalizes Agreement with Primex Pharmaceuticals AG
Regulatory News: Advicenne (Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suff...
Read full article »
Advicenne is a biopharmaceutical company that develops and commercializes tubular acidosis therapeutics for the treatment of kidney diseases.
Read more